Related Experiment Video
Updated: Nov 26, 2025

09:14
Exploring the Neural Correlates of Cognitive Reappraisal in Obsessive-Compulsive Disorder Using Task-based Functional Magnetic Resonance Imaging
Published on: March 14, 2025
617
Changes in the anterior cingulate cortex in Crohn's disease: A neuroimaging perspective
Ning Kong1,2, Chen Gao1,2, Maosheng Xu1,2
1The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
Brain and Behavior
|December 14, 2020
Summary
Crohn's disease affects the brain's anterior cingulate cortex (ACC), causing structural and functional changes. These brain alterations in the ACC are linked to pain and mood disorders in patients.
Area of Science:
- Neuroscience
- Gastroenterology
- Psychiatry
Background:
- Crohn's disease (CD) pathophysiology extends beyond the gut, impacting brain function.
- The anterior cingulate cortex (ACC) shows abnormalities in CD patients, affecting pain perception and emotional regulation.
- The ACC is a key region within the default mode network (DMN) and pain matrix.
Purpose of the Study:
- To review and summarize studies investigating changes in the ACC in Crohn's disease.
- To analyze structural, functional, and metabolic alterations in the ACC using neuroimaging.
- To correlate ACC changes with clinical symptoms such as abdominal pain and mood disorders.
Main Methods:
- Comprehensive PubMed literature search (1980-August 2020).
- Review focused on nine studies examining the ACC.
- Neuroimaging techniques included structural MRI, resting-state fMRI, and MR spectroscopy.
Main Results:
- Structural changes: Decreased gray matter volume and cortical thickness, increased gyrification.
- Functional changes: Altered functional connectivity (FC) within the DMN and between ACC and amygdala.
- Metabolic changes: Increased glutamate and decreased GABA, linked to abdominal pain.
Conclusions:
- The ACC exhibits significant structural, functional, and metabolic changes in Crohn's disease patients.
- ACC dysfunction is implicated in the development of depression, anxiety, and abdominal pain in CD.
- Modulating ACC pathways offers potential therapeutic targets for managing CD symptoms.

